Lepromatous leprosy in primigravida with early onset pre-eclampsia in third trimester: a rare case report

Authors

  • Ruby Bhatia Department of Obstetrics and Gynaecology, MMIMSR, Mullana, Ambala, Haryana, India
  • Neha Kumari Department of Obstetrics and Gynaecology, MMIMSR, Mullana, Ambala, Haryana, India
  • Vidushi Tewari Department of Obstetrics and Gynaecology, MMIMSR, Mullana, Ambala, Haryana, India
  • Sanjum Y. Malik Department of Obstetrics and Gynaecology, MMIMSR, Mullana, Ambala, Haryana, India
  • Rishu Goel Department of Obstetrics and Gynaecology, MMIMSR, Mullana, Ambala, Haryana, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20243613

Keywords:

Leprosy, Preeclampsia, MDT, Papule, NLEP

Abstract

Leprosy also called as Hansen's disease, one of the oldest infectious diseases in the world. It is a chronic condition that mostly affects the skin, mucous membranes, and peripheral nerves. Although leprosy is infrequently observed during pregnancy but when it occurs, can worsen and in the absence of treatment cause irreversible damage to the skin, limbs, nerves, and other organs. It is therefore necessary to have vigil eye for early diagnosis, management and treatment of leprosy during pregnancy for best maternal and fetal outcomes. We report a rarest in fact seen first time in 38 years of clinical practice, a primigravida 29-weeks pregnancy, early onset preeclampsia with lepromatous leprosy came to emergency with chief complaints of multiple erythematous papules arising all over the body mainly limbs and abdomen associated with intense pain. A diagnosis of lepromatous leprosy was made on the basis of biopsy report. Patient was treated with multidrug therapy (MDT) as per national leprosy elimination program (NLEP) successfully and delivered a healthy baby boy without any adverse maternal and perinatal outcomes. The infant growth following delivery was normal during follow up period till one year. Multidrug therapy consisting of dapsone, rifampicin and clofazimine is highly effective treatment for leprosy and considered safe for both mother and child hence treatment should be continued unchanged during pregnancy.

Metrics

Metrics Loading ...

References

Lazo-Porras M, Prutsky GJ, Barrionuevo P, Tapia JC, Ugarte-Gil C, Ponce OJ, et al. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis. BMC Infect Dis. 2020;20:1-4.

Lockwood DN, Sinha HH. Pregnancy and leprosy: a comprehensive literature review. Int J Leprosy Other Mycobacterial Dis. 1999;67(1):6-12.

Duncan ME, Pearson JM, Rees RJ. The association of pregnancy and leprosy. I Lepr Rev. 1981;52:245-62.

MOHFW. Update on leprosy cases in the country. 2023. Available at: https://pib.gov.in/Press ReleaseIframePage.aspx?PRID=1909081. Accessed on 09 August 2024.

Luft BJ, Remington JS. Effect of pregnancy on resistance to Listeria monocytogenes and Toxoplasma gondii infections in mice. Infect Immun. 1982;38:1164-71.

Duncan ME, Melsom R, Pearson JM, Ridley DS. The association of pregnancy and leprosy. I. New cases, relapse of cured patients and deterioration in patients on treatment during pregnancy and lactation-results of a prospective study of 154 pregnancies in 147 Ethiopian women. Leprosy Rev. 1981;52(3):245-62.

Tajiri I. Leprosy and childbirth. Int J Lepr. 1936;4(2):189-94.

King JA, Marks RA. Pregnancy and leprosy: a review of 52 pregnancies in 26 patients with leprosy. Am J Obstet Gynecol. 1958;76(2):438-42.

Downloads

Published

2024-11-28

Issue

Section

Case Reports